Description
SEBI issues a release order for Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C), indicating the recovery proceedings have been concluded.
Summary
SEBI has issued a Release Order for Recovery Certificate No. 4355 of 2021, which was issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C). This release order signifies the conclusion or withdrawal of recovery proceedings that were initiated against the company under the said recovery certificate.
Key Points
- Recovery Certificate No. 4355 of 2021 was issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C)
- SEBI has now issued a release order for this recovery certificate, dated March 17, 2026
- A companion completion order for the same RC (No. 4355 of 2021) was also issued on the same date
- The release order indicates that the enforcement/recovery proceedings against the company have been brought to a close
- Venmax Drugs and Pharmaceuticals Limited is the subject entity
Regulatory Changes
No new regulatory changes are introduced. This is an administrative order concluding existing enforcement proceedings under Recovery Certificate No. 4355 of 2021.
Compliance Requirements
No new compliance requirements are imposed on market participants. The order is specific to Venmax Drugs and Pharmaceuticals Limited and represents the closure of its recovery obligations under RC No. 4355 of 2021.
Important Dates
- Recovery Certificate No. 4355 of 2021: Originally issued in 2021
- Release Order Date: March 17, 2026
Impact Assessment
This order has minimal broader market impact. It is an administrative action specific to Venmax Drugs and Pharmaceuticals Limited, indicating the completion of SEBI’s recovery proceedings against the company. The issuance of both a release order and a completion order on the same date suggests the matter has been fully resolved, either through payment of dues or other settlement.
Impact Justification
Administrative release order for a recovery certificate against a specific entity, indicating closure of enforcement proceedings. Limited broader market impact.